22 oct
|
Alexion
|
Barcelona
Alexion, Astra
Zeneca Rare Disease, seeks a Director for Integral Value Access and Pricing in Neurology to lead NMOSD strategy across EU markets.
You will shape payer value propositions, HTA engagement, and lifecycle management with cross-functional partners to accelerate patient access for transformative therapies.
The role combines strategic leadership in value communications, evidence planning, and market access execution, with broad visibility and international scope in a hybrid Barcelona-based #J-18808-Ljbffr
📌 Global Neurology Access Lead – NMOSD | Hybrid (Barcelona)
🏢 Alexion
📍 Barcelona